Browse Guides  internal medicine  endocrine and metabolic disorders

Hypercalcaemia

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Prognosis

Survival is poor in patients with bony metastases. a b

Note:
  • Patients survive on average 10 weeks b
  • 85% of patients with breast cancer and a first episode of hypercalcaemia are dead within 8 years (95% CI: 80% to 90%) a

Expiry date: September 2004
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   S B   Ramirez
CAT Writers   CM   Ball , CJ   Wotton